An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

Curr Oncol · 2009 · PMC2722048 · PMID 19672416

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At 64 months, OS was superior in those who had switched to anastrozole, but the difference did not reach statistical significance 34 .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.